Intellipharmaceutics International Revenue

Pharmaceutical Manufacturing • Toronto, Ontario, Canada • 21-50 Employees

Intellipharmaceutics International revenue & valuation

Annual revenue	$495,348
Revenue per employee	$20,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$1,600,000
Total funding	$3,100,000

Key Contact at Intellipharmaceutics International

Isa Odidi

Chief Executive Officer, Co-Chief Scientific Officer, Chairman

Company overview

Headquarters	30 Worcester Rd, Etobicoke, ON M9W 5X2, CA
Phone number	+14167983001
Website	intellipharmaceutics.com
NAICS	3254
SIC	283
Keywords	Stability Studies, Generic Pharmaceuticals, Analytical Testing, Quality Control Testing, Abuse Deterrent, Abuse Deterrent Formulations, Category 1 Abuse Deterrent Sutdies, Contract Analytical Servics, Controlled-Release Drug Delivery, Hypermatrix (Tm) Technology
Founded	1998
Employees	21-50
Socials

Intellipharmaceutics International Email Formats

Intellipharmaceutics International uses 2 email formats. The most common is {first name}{last name} (e.g., johndoe@intellipharmaceutics.com), used 64.3% of the time.

Format	Example	Percentage
{first name}{last name}	johndoe@intellipharmaceutics.com	64.3%
{first initial}{last name}	jdoe@intellipharmaceutics.com	35.7%

About Intellipharmaceutics International

At Intellipharmaceutics, we are engaged in the research, development and commercialization of pharmaceutical products, both novel and generic, with a particular emphasis in the controlled-release & opioid abuse deterrence space. Intellipharmaceutics also operates a contract analytical services lab in Toronto that provides Methods Development, Validation & Transfer, Quality Control Testing, Stability Testing and Category 1 Abuse Deterrent Studies. Intellipharmaceutics International is currently trading on the OTCQB and TSX (OTCQB: IPCIF; TSX: IPCI).

Employees by Management Level

Total employees: 21-50

Seniority

Employees

Entry

Manager

C-Suite

Employees by Department

Intellipharmaceutics International has 14 employees across 5 departments.

Departments

Number of employees

Funding Data

Explore Intellipharmaceutics International's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2021-05-22	14	$3,100,000

Funding Insights

$3,100,000

Total funding amount

$3,100,000

Most recent funding amount

Number of funding rounds

Intellipharmaceutics International Tech Stack

Discover the technologies and tools that power Intellipharmaceutics International's digital infrastructure, from frameworks to analytics platforms.

Apache HTTP Server

Web servers

jQuery

JavaScript libraries

Google Tag Manager

Tag managers

Select2

JavaScript libraries

Browser-Update.org

JavaScript libraries

PHP

Programming languages

FancyBox

JavaScript libraries

Open Graph

Miscellaneous

PWA

Miscellaneous

Bootstrap

UI frameworks

Google Analytics

Analytics

Microsoft 365

Frequently asked questions

Intellipharmaceutics International is located in Toronto, Ontario, CA.

You can reach Intellipharmaceutics International at +14167983001.

Intellipharmaceutics International generates an estimated annual revenue of $495,348. This revenue figure reflects the company's market position and business performance in its industry.

Intellipharmaceutics International has an estimated valuation of $1,600,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Intellipharmaceutics International was founded in 1998, making it 28 years old. The company has established itself as a significant player in its industry over this time.

Intellipharmaceutics International has approximately 21-50 employees. The company continues to grow its workforce to support its business operations and expansion.

Intellipharmaceutics International has raised a total of $3,100,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Intellipharmaceutics International

Isa Odidi

Chief Executive Officer, Co-Chief Scientific Officer, Chairman

4.8

40,000 users